Company / Operating Cash Flow per Share
Avidity Biosciences, Inc. Operating Cash Flow per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$4.72
FY2025
5-year range
-$4.72 / -$1.63
FY2021-FY2025
Trend
-75.2%
vs FY2024
Sector context
#193 of 212
Health Care
What the data says
Among 212 Health Care companies, Avidity Biosciences, Inc. is in the bottom 9% for operating cash flow per share. Operating Cash Flow per Share has fluctuated over the past 8 years, ranging from $-4.72 in FY2025 to $0.92 in FY2019.
Based on SEC 10-K filings.
-4.72 in FY2025.
Declined from $-1.63 to $-4.72 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 9% in Health CareTop 91% of 212This company -$4.72 Sector average -$14.72
▼
+67.9% above sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 75.2% year-over-year.
- Ranks #193 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4.72 | -75.2% |
| FY2024 | -$2.70 | -65.3% |
| FY2023 | -$1.63 | +37.6% |
| FY2022 | -$2.61 | -14.1% |
| FY2021 | -$2.29 | -33.6% |
| FY2020 | -$1.71 | -286.7% |
| FY2019 | $0.92 | +123.5% |
| FY2018 | -$3.90 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026